Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Study of a Retroviral Replicating Vector Administered to Subjects With Recurrent Malignant Glioma

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2014 by Tocagen Inc.
Sponsor:
Information provided by (Responsible Party):
Tocagen Inc.
ClinicalTrials.gov Identifier:
NCT01156584
First received: July 1, 2010
Last updated: November 19, 2014
Last verified: November 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)
No publications provided by Tocagen Inc.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):